The invasive front in endometrial carcinoma: higher proliferation and associated derailment of cell cycle regulators

Human Pathology

Volumn 38, Issue 8, 2007, Pages 1232-1238

  Horrée, Nicole ^a   van Diest, Paul J ^a   Sie Go, Daisy M D S ^a   Heintz, A Peter M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Cancer; Cell cycle; Endometrium; Hypoxia; Immunohistochemistry; Invasive front

Indexed keywords

CARBONATE DEHYDRATASE IX; CYCLIN A; CYCLIN DEPENDENT KINASE 2; CYCLIN E; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; KI 67 ANTIGEN; VASCULOTROPIN;

ARTICLE; CELL CYCLE REGULATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; SCORING SYSTEM;

ADENOCARCINOMA, MUCINOUS; CARCINOMA, ENDOMETRIOID; CELL COUNT; CELL CYCLE PROTEINS; CELL PROLIFERATION; CYCLIN A; CYSTADENOCARCINOMA, SEROUS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; MYOMETRIUM; NEOPLASM INVASIVENESS; TUMOR MARKERS, BIOLOGICAL;

EID: 34447297300     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2007.01.008     Document Type: Article

References (40)

1. Aznavoorian S., Murphy A.N., Stetler-Stevenson W., et al. Molecular aspects of tumor cell invasion and metastasis. Cancer 71 (1993) 1368-1383
2. Kato N., Watanabe J., Jobo T., et al. Immunohistochemical expression of cyclin E in endometrial adenocarcinoma (endometrioid type) and its clinicopathological significance. J Cancer Res Clin Oncol 129 (2003) 222-226
3. Milde-Langosch K., and Riethdorf S. Role of cell-cycle regulatory proteins in gynecological cancer. J Cell Physiol 196 (2003) 224-244
4. Engelsen I.B., Stefansson I., Akslen L.A., et al. Pathologic expression of p53 or p16 in preoperative curettage specimens identifies high-risk endometrial carcinomas. Am J Obstet Gynecol 195 (2006) 979-986
5. Ito K., Sasano H., Matsunaga G., et al. Correlations between p21 expression and clinicopathological findings, p53 gene and protein alterations, and survival in patients with endometrial carcinoma. J Pathol 183 (1997) 318-324
6. Salvesen H.B., Iversen O.E., and Akslen L.A. Prognostic significance of angiogenesis and Ki-67, p53, and p21 expression: a population-based endometrial carcinoma study. J Clin Oncol 17 (1999) 1382-1390
7. Shih H.C., Shiozawa T., Kato K., et al. Immunohistochemical expression of cyclins, cyclin dependent kinases, tumor-suppressor gene products, Ki-67, and sex steroid receptors in endometrial carcinoma: positive staining for cyclin A as a poor prognostic indicator. Hum Pathol 34 (2003) 471-478
8. Rosen D.G., Yang G., Deavers M.T., et al. Cyclin E expression is correlated with tumor progression and predicts a poor prognosis in patients with ovarian carcinoma. Cancer 106 (2006) 1925-1932
9. Singhal S., Vachani A., Antin-Ozerkis D., et al. Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: a review. Clin Cancer Res 11 (2005) 3974-3986
10. Semenza G. Signal transduction to hypoxia-inducible factor 1. Biochem Pharmacol 64 (2002) 993-998
11. Sivridis E., Giatromanolaki A., Gatter K.C., et al. Association of hypoxia-inducible factors 1 alpha and 2 alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma. Cancer 95 (2002) 1055-1063
12. Bos R., Zhong H., Hanrahan C.F., et al. Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. J Natl Cancer Inst 93 (2001) 309-314
13. Vleugel M.M., Shvarts D., van der Wall E., et al. p300 and p53 levels determine activation of HIF-1 downstream targets in invasive breast cancer. Hum Pathol 37 (2006) 1085-1092
14. Greijer A.E., van der Groep P., Kemming D., et al. Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1). J Pathol 206 (2005) 291-304
15. Vaughan-Jones R.D., and Spitzer K.W. Role of bicarbonate in the regulation of intracellular pH in the mammalian ventricular myocyte. Biochem Cell Biol 80 (2002) 579-596
16. Choi K.S., Bae M.K., Jeong J.W., et al. Hypoxia-induced angiogenesis during carcinogenesis. J Biochem Mol Biol 36 (2003) 120-127
17. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106-130
18. Van Diest P.J., Baak J.P., Matze-Cok P., et al. Reproducibility of mitosis counting in 2,469 breast cancer specimens: results from the Multicenter Morphometric Mammary Carcinoma Project. Hum Pathol 23 (1992) 603-607
19. van Diest P.J. No consent should be needed for using leftover body material for scientific purposes. BMJ 325 (2002) 648-651
20. Georgiou L., Minopoulos G., Lirantzopoulos N., et al. Angiogenesis and p53 at the invading tumor edge: prognostic markers for colorectal cancer beyond stage. J Surg Res 131 (2006) 118-123
21. Guo P., Imanishi Y., Cackowski F.C., et al. Up-regulation of angiopoietin-2, matrix metalloprotease-2, membrane type 1 metalloprotease, and laminin 5γ2 correlates with the invasiveness of human glioma. Am J Pathol 166 (2005) 877-890
22. Hantschmann P., Lampe B., Beysiegel S., et al. Tumor proliferation in squamous cell carcinoma of the vulva. Int J Gynecol Pathol 19 (2000) 361-368
23. Jung A., Schrauder M., Oswald U., et al. The invasion front of human colorectal adenocarcinomas shows co-localization of nuclear beta-catenin, cyclin D1, and p16INK4A and is a region of low proliferation. Am J Pathol 159 (2001) 1613-1617
24. Palmqvist R., Sellberg P., Oberg A., et al. Low tumour cell proliferation at the invasive margin is associated with a poor prognosis in Dukes' stage B colorectal cancers. Br J Cancer 79 (1999) 577-581
25. Palmqvist R., Rutegard J.N., Bozoky B., et al. Human colorectal cancers with an intact p16/cyclin D1/pRb pathway have up-regulated p16 expression and decreased proliferation in small invasive tumor clusters. Am J Pathol 157 (2000) 1947-1953
26. Ramires M., David L., Leitao D., et al. Ki67 labelling index in gastric carcinomas. An immunohistochemical study using double staining for the evaluation of the proliferative activity of diffuse-type carcinomas. J Pathol 182 (1997) 62-67
27. Scarpino S., Cancellario d'Alena F., Di Napoli A., et al. Increased expression of Met protein is associated with up-regulation of hypoxia inducible factor-1 (HIF-1) in tumour cells in papillary carcinoma of the thyroid. J Pathol 202 (2004) 352-358
28. Sivridis E., Giatromanolaki A., Koukourakis M.I., et al. Thymidine phosphorylase expression in endometrial carcinomas. Clin Exp Metastasis 17 (1999) 445-450
29. Giatromanolaki A., Sivridis E., and Koukourakis M.I. Tumour angiogenesis: vascular growth and survival. APMIS 112 (2004) 431-440
30. Koistinen H., Seppala M., Knuutila S., et al. Extracellular matrix-induced changes in expression of cell cycle-related proteins and proteasome components in endometrial adenocarcinoma cells. Gynecol Oncol 102 (2006) 546-551
31. Papadopoulos I., Giatromanolaki A., Koukourakis M.I., et al. Tumour angiogenic activity and vascular survival ability in bladder carcinoma. J Clin Pathol 57 (2004) 250-255
32. Sivridis E., Giatromanolaki A., and Koukourakis M.I. "Stromatogenesis" and tumor progression. Int J Surg Pathol 12 (2004) 1-9
33. Sivridis E., Giatromanolaki A., and Koukourakis M.I. Proliferating fibroblasts at the invading tumour edge of colorectal adenocarcinomas are associated with endogenous markers of hypoxia, acidity, and oxidative stress. J Clin Pathol 58 (2005) 1033-1038
34. Giatromanolaki A., Koukourakis M.I., Sivridis E., et al. 'Invading edge vs. inner' (edvin) patterns of vascularization: an interplay between angiogenic and vascular survival factors defines the clinical behaviour of non-small cell lung cancer. J Pathol 192 (2000) 140-149
35. Vleugel M.M., Greijer A.E., Shvarts A., et al. Differential prognostic impact of hypoxia induced and diffuse HIF-1 alpha expression in invasive breast cancer. J Clin Pathol 58 (2005) 172-177
36. Dissanayake U., Johnson N.W., and Warnakulasuriya K.A. Comparison of cell proliferation in the centre and advancing fronts of oral squamous cell carcinomas using Ki-67 index. Cell Prolif 36 (2003) 255-264
37. Bergstrom C., Palmqvist R., Denekamp J., et al. Factors influencing the estimates of proliferative labelling indices in rectal cancer. Radiother Oncol 46 (1998) 169-177
38. Svensson S., Nilsson K., Ringberg A., et al. Invade or proliferate? Two contrasting events in malignant behavior governed by p16(INK4a) and an intact Rb pathway illustrated by a model system of basal cell carcinoma. Cancer Res 63 (2003) 1737-1742
39. Tringler B., Gup C.J., Singh M., et al. Evaluation of p16INK4a and pRb expression in cervical squamous and glandular neoplasia. Hum Pathol 35 (2004) 689-696
40. Armes J.E., Lourie R., de Silva M., et al. Abnormalities of the RB1 pathway in ovarian serous papillary carcinoma as determined by overexpression of the p16(INK4A) protein. Int J Gynecol Pathol 24 (2005) 363-368